Skip Navigation

COVID-19 Update

Due to interest in the COVID-19 vaccines, we are experiencing an extremely high call volume. Please understand that our phone lines must be clear for urgent medical care needs. We are unable to accept phone calls to schedule COVID-19 vaccinations at this time. When this changes, we will update this website. Our vaccine supply remains limited. Read all COVID-19 Vaccine Information.

Patient Care Options | Visitor Guidelines | Coronavirus Information | Self-Checker | Get Email Alerts

Julie Jisun Paik, M.D., M.H.S.

Headshot of Julie Jisun Paik
  • Director of Clinical Trials at the Johns Hopkins Myositis Center
  • Assistant Professor of Medicine

Specializes in: Adults (18+ years)

Female

Languages: English, Korean

Expertise

Myositis, Rheumatology, Scleroderma

Research Interests

Myositis, dermatomyositis, scleroderma, scleroderma associated myopathy ...read more

Request an Appointment

Insurance Information

Maryland Phone

443-997-1552

Outside of Maryland

410-464-6641
Request Appointment

International Patients

+1-410-502-7683
Request Appointment

Locations

Johns Hopkins Bayview Medical Center

Appointment Phone: 443-997-1552
301 Mason Lord Drive
Myositis Center
Baltimore, MD 21224 map
Phone: 410-550-6962

Johns Hopkins Bayview Medical Center

5501 Hopkins Bayview Circle
Asthma and Allergy Center 1B.1
Baltimore, MD 21224 map
Phone: 410-550-7715

Background

Dr. Julie Paik completed her medical school training at the George Washington University School of Medicine in Washington, DC. She then completed her residency and chief residency at UCLA-Cedars-Sinai/VA Medical Center in Los Angeles, California. 

She completed rheumatology fellowship at Johns Hopkins and joined the faculty in 2013.  She currently sees patients at the Johns Hopkins Myositis Center and Scleroderma Center. Her research interests are in myositis and scleroderma or overlap myositis. She also has a special interest in novel therapeutics in refractory dermatomyositis. 

This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida.

...read more

Titles

  • Director of Clinical Trials at the Johns Hopkins Myositis Center
  • Assistant Professor of Medicine

Departments / Divisions

Centers & Institutes

Education

Degrees

  • MD; The George Washington University School of Medicine (2006)

Residencies

  • Internal Medicine; Cedars-Sinai Medical Center (2010)

Fellowships

  • Rheumatology; Johns Hopkins University School of Medicine (2013)

Additional Training

  • American Board of Internal Medicine / Diplomate
  • American Board of Internal Medicine - Rheumatology / Diplomate

Research & Publications

Research Summary

Muscle disease in scleroderma is common and is associated with poor outcomes such as disability and sudden cardiac death. We have developed a sub-cohort of weak scleroderma patients and are beginning to study the mechanisms driving muscle disease and also interventions to halt or improve strength in this special group of patients. 

My secondary research interest is in novel therapeutics in refractory dermatomyositis. In particular, I am interested in JAK inhibitor therapy in refractory dermatomyositis and have led a pilot study of tofacitinib in refractory dermatomyositis. 

Clinical Trial Keywords

Dermatomyositis, Scleroderma

Clinical Trials

Dr. Paik is a principal investigator in the study of tofacitinib in refractory dermatomyositis. She is also a co-investigator in other trials in scleroderma and myositis. 

Selected Publications

Paik JJ, Wigley FM, Lloyd TE, Corse AM, Casciola-Rosen L, Shah AA, Boin F, Hummers LK, Mammen AL. The spectrum of muscle histopathologic findings in 42 weak scleroderma patients. Arthritis Care Res (Hoboken). 2015 May 18. Doi:10.1002/acr.22620

Paik JJ, Casciola-Rosen L, Shin JY, Albayda J, Tiniakou E, Leung DG, Gutierrez-Alamillo L, Perin J, Florea L, Antonescu C, Leung SG, Purwin G, Koenig A, Christopher-Stine L. Study of tofacitinib in refractory dermatomyositis (STIR): An open label pilot study of 10 patients. Arthritis Rheumatology 2020 Dec 1. doi:10.1002/art.41602 online ahead of print

Baig SS and Paik JJ. Inflammatory muscle disease- an update. Best Pract Res Clin Rheumatol. 2020 Feb; 34(1):101484

Paik JJ. Muscle disease in scleroderma. Curr Opin Rheumatol. 2018 Nove; 30(6):576-580

Paik JJ, Wigley FM, Shah AA, Corse AM, Casciola-Rosen L, Hummers LK, Mammen AL. Association of fibrosing myopathy in systemic sclerosis and higher mortality. Arthritis Care Res (Hoboken) 2017 Nov: 69 (11): 1764-1770

Academic Affiliations & Courses

Graduate Program Affiliation

GTPCI (Graduate Training Program of Clinical Investigation)

Activities & Honors

Honors

  • Clinical to Research Transition Award, Arthritis Foundation, 2013
  • Early Investigator Award, Doris Duke Foundation, 2017

Memberships

  • American College of Rheumatology
  • International Myositis Assessment and Clinical Research

Professional Activities

  • Member, Diversity Council

Patient Ratings & Comments

The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

  • ...Loading ratings...
  • ... 
  • ... 
  • ... 
  • ... 
  • ... 

Comments

Loading...
Is this you? Edit Profile
back to top button